Search Results 1261-1270 of 17018 for Nilutamide

  1. Vulvar cancer - Doctors and departments - Mayo Clinic

    Learn about this rare cancer that forms on the skin that surrounds the urethra and vagina. Treatments include surgery, radiation and chemotherapy.

  2. Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  3. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  4. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  5. Adrenal cancer - Doctors and departments - Mayo Clinic

    Learn about this rare cancer that begins in the adrenal glands. Find out about symptoms, diagnosis and treatment.

  6. Arthritis - Doctors and departments - Mayo Clinic

    Learn about how different types of arthritis affect joints in different ways, along with how to get relief from arthritis pain.

  7. Miconazole (topical route) - Side effects & dosage - Mayo Clinic

    Miconazole belongs to the group of medicines called antifungals. Topical miconazole is used to treat some types of fungus infections. Some of these preparations ...

  8. Pediatrics Clinical Trials - Medical Professionals

    Early diagnosis of nerve root avulsion injuries following brachial plexus trauma remain a barrier to the early treatment of these complex injuries.

  9. Amyloidosis - Doctors and departments - Mayo Clinic

    This rare disease caused by a buildup of the protein amyloid can affect different organs in different people. Find out how early and accurate diagnosis can ...

  10. Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies - Mayo Clinic

    This is a phase 1, open-label, multicenter, ascending-dose escalation study of REGN2810, alone and in combination with other anti-cancer therapies in patients ...